Advances in the management of respiratory distress syndrome (RDS) ensure that clinicians must continue to revise current practice. We report the third update of the European Guidelines for the Management of RDS by a European panel of expert neonatologists including input from an expert perinatal obstetrician based on available literature up to the beginning of 2016. Optimizing the outcome for babies with RDS includes consideration of when to use antenatal steroids, and good obstetric practice includes methods of predicting the risk of preterm delivery and also consideration of whether transfer to a perinatal centre is necessary and safe. Methods for optimal delivery room management have become more evidence based, and protocols for lung protection, including initiation of continuous positive airway pressure and titration of oxygen, should be implemented from soon after birth. Surfactant replacement therapy is a crucial part of the management of RDS, and newer protocols for surfactant administration are aimed at avoiding exposure to mechanical ventilation, and there is more evidence of differences among various surfactants in clinical use. Newer methods of maintaining babies on non-invasive respiratory support have been developed and offer potential for greater comfort and less chronic lung disease. As technology for delivering mechanical ventilation improves, the risk of causing lung injury should decrease although minimizing the time spent on mechanical ventilation using caffeine and if necessary postnatal steroids are also important considerations. Protocols for optimizing the general care of infants with RDS are also essential with good temperature control, careful fluid and nutritional management, maintenance of perfusion and judicious use of antibiotics all being important determinants of best outcome.

Keywords:
Antenatal steroids, Continuous positive airway pressure, Evidence-based practice, Hyaline membrane disease, Mechanical ventilation, Nutrition, Oxygen supplementation, Patent ductus arteriosus, Preterm infant, Respiratory distress syndrome
1.
Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015;314:1039-1051.
2.
Sweet D, Bevilacqua G, Carnielli V, Greisen G, Plavka R, Saugstad OD, Simeoni U, et al; Working Group on Prematurity of the World Association of Perinatal Medicine, European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med 2007;35:175-186.
3.
Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, et al; European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2010 update. Neonatology 2010;97:402-417.
4.
Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, et al; European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2013 update. Neonatology 2013;103:353-368.
6.
Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schünemann, HJ; GRADE Working Group: Going from evidence to recommendations. BMJ 2008;336:1049-1051.
7.
Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA: Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev 2013;7:CD004947.
8.
Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, et al; OPPTIMUM study group: Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): multicentre, randomised, double-blind trial. Lancet 2016;387:2106-2116.
9.
Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim E, Tabor A; PREDICT Group: Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol 2011;38:272-280.
10.
Alfirevic Z, Stampalija T, Roberts D, Jorgensen AL: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev 2012;4:CD008991.
11.
Van Baaren GJ, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, et al: Predictive value of cervical length measurement and fibronectin testing in threatened preterm labor. Obstet Gynecol 2014;123:1185-1192.
12.
Rautava L, Eskelinen J, Häkkinen U, Lehtonen L; PERFECT Preterm Infant Study Group: 5-year morbidity among very preterm infants in relation to level of hospital care. JAMA Pediatr 2013;167:40-46.
13.
Kenyon S, Boulvain M, Neilson JP: Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2013;12:CD001058.
14.
Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D: Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009;1:CD004661.
15.
Darlow B, Austin N, French N, Campbell C, Carse E, Hayes M, et al: School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo. JAMA 2014;312:1105-1113.
16.
Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ: Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 2012;345:e6226.
17.
Tocolysis for women in preterm labour. Green-top guideline No 1b, February 2011. Royal College of Obstetricians and Gynaecologists. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_1b.pdf.
18.
Roberts D, Dalziel S: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3:CD004454.
19.
Manktelow BN, Lal MK, Field DJ, Sinha SK: Antenatal corticosteroids and neonatal outcomes according to gestational age: a cohort study. Arch Dis Child Fetal Neonatal Ed 2010;95:F95-F98.
20.
Boghossian NS, McDonald SA, Bell EF, Carlo WA, Brumbaugh JE, Stoll BJ, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Association of antenatal corticosteroids with mortality, morbidity, and neurodevelopmental outcomes in extremely preterm multiple gestation infants. JAMA Pediatr 2016;170:593-601.
21.
Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, et al: Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 2016;374:1311-1320.
22.
Sotiriadis A, Makrydimas G, Papatheodorou S, Ioannidis JP: Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term. Cochrane Database Syst Rev 2009;4:CD006614.
23.
Crowther CA, McKinlay CJD, Middleton P, Harding JE: Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev 2015;7:CD003935.
24.
World Health Organization:WHO Recommendations on Interventions to Improve Preterm Birth Outcomes. Geneva, WHO, 2015.
25.
Asztalos EV, Murphy KE, Willan AR, Matthews SG, Ohlsson A, Saigal S, et al: Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr 2013;167:1102-1110.
26.
Althabe F, Belizán JM, McClure EM, Hemingway-Foday J, Berrueta M, Mazzoni A, et al: A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet 2015;385:629-639.
27.
American College of Obstetricians and Gynecologists: ACOG committee opinion No 559: Cesarean delivery on maternal request. Obstet Gynecol 2013;121:904-907.
28.
Wyllie J, Bruinenberg J, Roehr CC, Rüdiger M, Trevisanuto D, Urlesberger B: European Resuscitation Council guidelines for resuscitation 2015. Section 7: resuscitation and support of transition of babies at birth. Resuscitation 2015;95:249-263.
29.
Saugstad OD: Delivery room management of term and preterm newly born infants. Neonatology 2015;107:365-371.
30.
Bhatt S, Alison BJ, Wallace EM, Crossley KJ, Gill AW, Kluckow M, te Pas AB, et al: Delaying cord clamping until ventilation onset improves cardiovascular function at birth in preterm lambs. J Physiol 2013;591:2113-2126.
31.
Rabe H, Diaz-Rossello JL, Duley L, Dowswell T: Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev 2012;8:CD003248.
32.
Katheria AC, Truong G, Cousins L, Oshiro B, Finer NN: Umbilical cord milking versus delayed cord clamping in preterm infants. Pediatrics 2015;136:61-69.
33.
Al-Wassia H, Shah PS: Efficacy and safety of umbilical cord milking at birth: a systematic review and meta-analysis JAMA Pediatr 2015;169:18-25.
34.
Tarnow-Mordi WO, Duley L, Field D, Marlow N, Morris J, Newnham J, et al: Timing of cord clamping in very preterm infants: more evidence is needed. Am J Obstet Gynecol 2014;211:118-123.
35.
Mercer JS, Erickson-Owens DA, Vohr BR, Tucker RJ, Parker AB, Oh W, Padbury JF: Effects of placental transfusion on neonatal and 18 month outcomes in preterm infants: a randomized controlled trial. J Pediatr 2016;168:50-55.
37.
Saugstad OD, Aune D, Aguar M, Kapadia V, Finer N, Vento M: Systematic review and meta-analysis of optimal initial fraction of oxygen levels in the delivery room at ≤32 weeks. Acta Paediatr 2014;103:44-751.
38.
Vento M, Cubells E, Escobar JJ, Escrig R, Aguar M, Brugada M, et al: Oxygen saturation after birth in preterm infants treated with continuous positive airway pressure and air: assessment of gender differences and comparison with a published nomogram. Arch Dis Child Fetal Neonatal Ed 2013;98:F228-F232.
39.
Kapadia VS, Chalak LF, Sparks JE, Allen JR, Savani RC, Wyckoff MH: Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics 2013;132:e1488-e1496.
40.
Oei JL, Vento M, Rabi Y, Wright I, Finer N, Rich W, et al: Higher or lower oxygen for delivery room resuscitation of preterm infants below 28 completed weeks gestation: a meta-analysis. Arch Dis Child Fetal Neonatal Ed 2016, Epub ahead of print.
41.
Szyld E, Aguilar A, Musante GA, Vain N, Prudent L, Fabres J, Carlo WA; Delivery Room Ventilation Devices Trial Group: Comparison of devices for newborn ventilation in the delivery room. J Pediatr 2014;165:234-239.
42.
Kelleher J, Bhat R, Salas AA, Addis D, Mills EC, Mallick H, et al: Oronasopharyngeal suction versus wiping of the mouth and nose at birth: a randomised equivalency trial. Lancet 2013;382:326-330.
43.
McCarthy LK, Twomey AR, Molloy EJ, Murphy JF, O'Donnell CP: A randomized trial of nasal prong or face mask for respiratory support for preterm newborns. Pediatrics 2013;132:e389-e395.
44.
Jobe AH, Ikegami M: Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998;53:81-94.
45.
O'Donnell CP, Bruschettini M, Davis PG, Morley CJ, Moja L, Calevo MG, Zappettini S: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes. Cochrane Database Syst Rev 2015;7:CD004953.
46.
American Academy of Pediatrics Committee on Fetus and Newborn: Respiratory support in preterm infants at birth. Pediatrics 2014;133:171-174.
47.
Stevens TP, Harrington EW, Blennow M, Soll RF: Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007;4:CD003063.
48.
Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, et al: Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011;378:1627-1633.
49.
Dargaville PA, Aiyappan A, de Paoli AG, Kuschel CA, Kamlin CO, Carlin JB, Davis PG: Minimally invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed 2013;98:F122-F126.
50.
Göpel W, Kribs A, Härtel C, Avenarius S, Teig N, Groneck P, et al: Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants. Acta Paediatr 2015;104:241-246.
51.
Kribs A, Roll C, Göpel W, Wieg C, Groneck P, Laux R, et al: Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr 2015;169:723-730.
52.
Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U: Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics 2013;131:e502-e509.
53.
More K, Sakhuja P, Shah PS: Minimally invasive surfactant administration in preterm infants: a meta-narrative review. JAMA Pediatr 2014;168:901-908.
54.
Minocchieri S, Knoch S, Schoel WM, Ochs M, Nelle M: Nebulizing poractant alfa versus conventional instillation: ultrastructural appearance and preservation of surface activity. Pediatr Pulmonol 2014;49:348-356.
55.
Ardell S, Pfister RH, Soll R: Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2015;8:CD000144.
56.
Pfister RH, Soll R, Wiswell TE: Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2007;4:CD006069.
57.
Curstedt T, Halliday HL, Speer CP: A unique story in neonatal research: the development of a porcine surfactant. Neonatology 2015;107:321-329.
58.
Singh N, Halliday HL, Stevens TP, Suresh G, Soll R, Rojas-Reyes MX: Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2015;12:CD010249.
59.
Bahadue FL, Soll R: Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2012;11:CD001456.
60.
Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al: Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999;103:E24.
61.
Isayama T, Chai-Adisaksopha C, McDonald SD: Noninvasive ventilation with vs without early surfactant to prevent chronic lung disease in preterm infants: a systematic review and meta-analysis. JAMA Pediatr 2015;169:731-739.
62.
Agertoft L, Djernes B, Nathan E, Reinholdt J, Dargaville PA, Aiyappan A, et al: Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences. Neonatology 2013;104:8-14.
63.
Verder H, Ebbesen F, Fenger-Grøn J, Henriksen TB, Andreasson B, Bender L, et al: Early surfactant guided by lamellar body counts on gastric aspirate in very preterm infants. Neonatology 2013;104:116-122.
64.
Soll R, Ozek E: Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2009;1:CD000141.
65.
Dani C, Corsini I, Poggi C: Risk factors for intubation-surfactant-extubation (INSURE) failure and multiple INSURE strategy in preterm infants. Early Hum Dev 2012;88(suppl 1):S3-S4.
66.
Brix N, Sellmer A, Jensen MS, Pedersen LV, Henriksen TB: Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study. BMC Pediatr 2014;14:155.
67.
Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, Tarnow-Mordi W; NeOProM Collaborative Group: NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr 2011;11:6.
68.
SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network; Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, Laptook AR, et al: Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010;362:1959-1969.
69.
BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group; Stenson BJ, Tarnow-Mordi WO, Darlow BA, Simes J, Juszczak E, Askie L, et al: Oxygen saturation and outcomes in preterm infants. N Engl J Med 2013;368:2094-2104.
70.
Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y, et al; Canadian Oxygen Trial (COT) Group: Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA 2013;309:2111-2120.
71.
BOOST-II Australia and United Kingdom Collaborative Groups; Tarnow-Mordi W, Stenson B, Kirby A, Juszczak E, Donoghoe M, Deshpande S, et al: Outcomes of two trials of oxygen-saturation targets in preterm infants. N Engl J Med 2016;374:749-760.
72.
Saugstad OD, Aune D: Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies. Neonatology 2014;105:55-63.
73.
Stenson BJ: Oxygen saturation targets for extremely preterm infants after the NeOProM trials. Neonatology 2016;109:352-358.
74.
Sola A, Golombek SG, Montes Bueno MT, Lemus-Varela L, Zuluaga C, Domínguez F, et al: Safe oxygen saturation targeting and monitoring in preterm infants: can we avoid hypoxia and hyperoxia? Acta Paediatr 2014;103:1009-1018.
75.
Van Zanten HA, Tan RN, van den Hoogen A, Lopriore E, te Pas AB: Compliance in oxygen saturation targeting in preterm infants: a systematic review. Eur J Pediatr 2015;174:1561-1572.
76.
Lim K, Wheeler KI, Gale TJ, Jackson HD, Kihlstrand JF, Sand C, et al: Oxygen saturation targeting in preterm infants receiving continuous positive airway pressure. J Pediatr 2014;164:730-736.
77.
Poets CF, Roberts RS, Schmidt B, Whyte RK, Asztalos EV, Bader D, et al: Association between intermittent hypoxemia or bradycardia and late death or disability in extremely preterm infants. JAMA 2015;314:595-603.
78.
Van Kaam AH, Hummler HD, Wilinska M, Swietlinski J, Lal MK, te Pas AB, et al: Automated versus manual oxygen control with different saturation targets and modes of respiratory support in preterm infants. J Pediatr 2015;167:545-550.
79.
Davis PG, Henderson-Smart DJ: Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2003;2:CD000143.
80.
Rojas-Reyes MX, Morley CJ, Soll R: Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012;3:CD000510.
81.
Davis PG, Morley CJ, Owen LS: Non-invasive respiratory support of preterm neonates with respiratory distress syndrome: continuous positive airway pressure and nasal intermittent positive pressure ventilation. Semin Fetal Neonatal Med 2009;14:14-20.
82.
De Paoli AG, Davis PG, Faber B, Morley CJ: Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates. Cochrane Database Syst Rev 2002;3:CD002977.
83.
Kieran EA, Twomey AR, Molloy EJ, Murphy JF, O'Donnell CP: Randomized trial of prongs or mask for nasal continuous positive airway pressure in preterm infants. Pediatrics 2012;130:e1170-e1176.
84.
Lampland AL, Plumm B, Worwa C, Meyers P, Mammel MC: Bi-level CPAP does not improve gas exchange when compared with conventional CPAP for the treatment of neonates recovering from respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 2015;100:F31-F34.
85.
Lemyre B, Davis PG, de Paoli AG, Kirpalani H: Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev 2014;9:CD003212.
86.
Dumpa V, Katz K, Northrup V, Bhandari V: SNIPPV versus NIPPV: does synchronization matter? J Perinatol 2012;32:438-442.
87.
Bancalari E, Claure N: The evidence for non-invasive ventilation in the preterm infant. Arch Dis Child Fetal Neonatal Ed 2013;98:F98-F102.
88.
Kirpalani H, Millar D, Lemyre B, Yoder BA, Chiu A, Roberts RS; NIPPV Study Group: A trial comparing noninvasive ventilation strategies in preterm infants. N Engl J Med 2013;369:611-620.
89.
Millar D, Lemyre B, Kirpalani H, Chiu A, Yoder BA, Roberts RS: A comparison of bilevel and ventilator-delivered non-invasive respiratory support. Arch Dis Child Fetal Neonatal Ed 2016;101:21-25.
90.
Wilkinson D, Andersen C, O'Donnell CP, de Paoli AG, Manley BJ: High flow nasal cannula for respiratory support in preterm infants. Cochrane Database Syst Rev 2016;2:CD006405.
91.
Reynolds P, Leontiadi S, Lawson T, Otunla T, Ejiwumi O, Holland N: Stabilisation of premature infants in the delivery room with nasal high flow. Arch Dis Child Fetal Neonatal Ed 2016;101:F284-F287.
92.
Roberts CT, Owen LS, Manley BJ, Donath SM, Davis PG: A multicentre, randomised controlled, non-inferiority trial, comparing high flow therapy with nasal continuous positive airway pressure as primary support for preterm infants with respiratory distress (the HIPSTER trial): study protocol. BMJ Open 2015;5:e008483.
93.
SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network; Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, et al: Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010;362:1970-1979.
94.
Erickson SJ, Grauaug A, Gurrin L, Swaminathan M: Hypocarbia in the ventilated preterm infant and its effect on intraventricular haemorrhage and bronchopulmonary dysplasia. J Paediatr Child Health 2002;38:560-562.
95.
Ambalavanan N, Carlo WA, Wrage LA, Das A, Laughon M, Cotten CM, et al; SUPPORT Study Group of the NICHD Neonatal Research Network: PaCO2 in surfactant, positive pressure, and oxygenation randomised trial (SUPPORT). Arch Dis Child Fetal Neonatal Ed 2015;100:F145-F149.
96.
Peng W, Zhu H, Shi H, Liu E: Volume-targeted ventilation is more suitable than pressure-limited ventilation for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2014;99:F158-F165.
97.
Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG: Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev 2010;11:CD003666.
98.
Keszler M, Nassabeh-Montazami S, Abubakar K: Evolution of tidal volume requirement during the first 3 weeks of life in infants <800 g ventilated with volume guarantee. Arch Dis Child Fetal Neonatal Ed 2009;94:F279-F282.
99.
Rimensberger PC, Cox PN, Frndova H, Bryan AC: The open lung during small tidal volume ventilation: concepts of recruitment and ‘optimal' positive end-expiratory pressure. Crit Care Med 1999;27:1946-1952.
100.
De Jaegere A, van Veenendaal MB, Michiels A, van Kaam AH: Lung recruitment using oxygenation during open lung high-frequency ventilation in preterm infants. Am J Respir Crit Care Med 2006;174:639-645.
101.
Cools F, Offringa M, Askie LM: Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 2015;3:CD000104.
102.
Zivanovic S, Peacock J, Alcazar-Paris M, Lo JW, Lunt A, Marlow N, Calvert S, Greenough A; United Kingdom Oscillation Study Group: Late outcomes of a randomized trial of high-frequency oscillation in neonates. N Engl J Med 2014;370:1121-1130.
103.
Manley BJ, Doyle LW, Owen LS, Davis PG: Extubating extremely preterm infants: predictors of success and outcomes following failure. J Pediatr 2016;173:45-49.
104.
Danan C, Durrmeyer X, Brochard L, Decobert F, Benani M, Dassieu G: A randomized trial of delayed extubation for the reduction of reintubation in extremely preterm infants. Pediatr Pulmonol 2008;43:117-124.
105.
Buzzella B, Claure N, D'Ugard C, Bancalari E: A randomized controlled trial of two nasal continuous positive airway pressure levels after extubation in preterm infants. J Pediatr 2014;164:46-51.
106.
Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al; Caffeine for Apnea of Prematurity Trial Group: Caffeine therapy for apnea of prematurity. N Engl J Med 2006;354:2112-2121.
107.
Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al; Caffeine for Apnea of Prematurity Trial Group: Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357:1893-1902.
108.
Dobson NR, Patel RM, Smith PB, Kuehn DR, Clark J, Vyas-Read S, et al: Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants. J Pediatr 2014;164:992-998.
109.
Taha D, Kirkby S, Nawab U, Dysart KC, Genen L, Greenspan JS, Aghai ZH: Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants. J Matern Fetal Neonatal Med 2014;27:1698-1702.
110.
Lodha A, Seshia M, McMillan DD, Barrington K, Yang J, Lee SK, Shah PS; Canadian Neonatal Network: Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr 2015;169:33-38.
111.
Steer P, Flenady V, Shearman A, Charles B, Gray PH, Henderson-Smart D, et al: High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2004;89:F499-F503.
112.
Mohammed S, Nour I, Shabaan AE, Shouman B, Abdel-Hady H, Nasef N: High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial. Eur J Pediatr 2015;174:949-956.
113.
Woodgate PG, Davies MW: Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants. Cochrane Database Syst Rev 2001;2:CD002061.
114.
Thome UH, Genzel-Boroviczeny O, Bohnhorst B, Schmid M, Fuchs H, Rohde O, et al; PHELBI Study Group: Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trial. Lancet Respir Med 2015;3:534-543.
115.
Doyle LW, Ehrenkranz RA, Halliday HL: Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2014;5:CD001145.
116.
Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC: An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia. J Pediatr 2014;165:1258-1260.
117.
Jefferies AL: Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Paediatr Child Health 2012;17:573-574.
119.
Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, et al; PREMILOC Trial Study Group: Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet 2016;387:1827-1836.
120.
Bassler D, Plavka R, Shinwell ES, Hallman M, Jarreau PH, Carnielli V, et al; NEUROSIS Trial Group: Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N Engl J Med 2015;373:1497-1506.
121.
Yeh TF, Chen CM, Wu SY, Husan Z, Li TC, Hsieh WS, et al: Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia. Am J Respir Crit Care Med 2016;193:86-95.
122.
Phillipos E, Solevåg AL, Pichler G, Aziz K, van Os S, O'Reilly M, et al: Heart rate assessment immediately after birth. Neonatology 2016;109:130-138.
123.
Bruschettini M, Romantsik O, Zappettini S, Ramenghi LA, Calevo MG: Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality. Cochrane Database Syst Rev 2016;2:CD011494.
124.
Hyttel-Sorensen S, Pellicer A, Alderliesten T, Austin T, van Bel F, Benders M, et al: Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ 2015;350:g7635.
125.
Reilly MC, Vohra S, Rac VE, Dunn M, Ferrelli K, Kiss A, et al: Randomized trial of occlusive wrap for heat loss prevention in preterm infants. J Pediatr 2015;166:262-268.
126.
McCarthy LK, Molloy EJ, Twomey AR, Murphy JF, O'Donnell CP: A randomized trial of exothermic mattresses for preterm newborns in polyethylene bags. Pediatrics 2013;132:e135-e141.
127.
Meyer MP, Hou D, Ishrar NN, Dito I, te Pas AB: Initial respiratory support with cold, dry gas versus heated humidified gas and admission temperature of preterm infants. J Pediatr 2015;166:245-250.
128.
Sinclair JC: Servo-control for maintaining abdominal skin temperature at 36°C in low birth weight infants. Cochrane Database Syst Rev 2002;1: D001074.
129.
Conde-Agudelo A, Díaz-Rossello JL: Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev 2014;4:CD002771.
130.
Cho ES, Kim SJ, Kwon MS, Cho H, Kim EH, Jun EM, Lee S: The effects of kangaroo care in the neonatal intensive care unit on the physiological functions of preterm infants, maternal-infant attachment, and maternal stress. J Pediatr Nurs 2016;31:430-438.
131.
Bell EF, Acarregui MJ: Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2014;12:CD000503.
132.
Barrington KJ: Management during the first 72 h of age of the periviable infant: an evidence-based review. Semin Perinatol 2014;38:17-24.
133.
Trivedi A, Sinn JKH: Early versus late administration of amino acids in preterm infants receiving parenteral nutrition. Cochrane Database Syst Rev 2013;7:CD008771.
134.
Moyses HE, Johnson MJ, Leaf AA, Cornelius VR: Early parenteral nutrition and growth outcomes in preterm infants: a systematic review and meta-analysis. Am J Clin Nutr 2013;97:816-826.
135.
Bonsante F, Iacobelli S, Latorre G, Rigo J, De Felice C, Robillard PY, et al: Initial amino acid intake influences phosphorus and calcium homeostasis in preterm infants - it is time to change the composition of the early parenteral nutrition. PLoS One 2013;8:e72880.
136.
Vlaardingerbroek H, Vermeulen MJ, Rook D, van den Akker CH, Dorst K, Wattimena JL, et al: Safety and efficacy of early parenteral lipid and high-dose amino acid administration to very low birth weight infants. J Pediatr 2013;163:638-644.
137.
Morgan J, Bombell S, McGuire W: Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants. Cochrane Database Syst Rev 2013;3:CD000504.
138.
Morgan J, Young L, McGuire W: Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2014;12:CD001970.
139.
Morgan J, Young L, McGuire W: Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2015;10:CD001241.
140.
Quigley M, McGuire W: Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2014;4:CD002971.
141.
Polin RA, Watterberg K, Benitz W, Eichenwald E: The conundrum of early-onset sepsis. Pediatrics 2014;133:1122-1123.
142.
Soll RF, Edwards WH: Antibiotic use in neonatal intensive care. Pediatrics 2015;135:928-929.
143.
Cotton CM: Antibiotic stewardship: reassessment of guidelines for management of neonatal sepsis. Clin Perinatol 2015;42:195-206.
145.
Faust K, Härtel C, Preuss M, Rabe H, Roll C, Emeis M, et al; Neocirculation Project and the German Neonatal Network (GNN): Short-term outcome of very-low-birthweight infants with arterial hypotension in the first 24 h of life. Arch Dis Child Fetal Neonatal Ed 2015;100:F388-F392.
146.
Batton B, Li L, Newman NS, Das A, Watterberg KL, Yoder BA, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Evolving blood pressure dynamics for extremely preterm infants. J Perinatol 2014;34:301-305.
147.
Batton B, Li L, Newman NS, Das A, Watterberg KL, Yoder BA, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Use of antihypotensive therapies in extremely preterm infants. Pediatrics 2013;131:e1865-e1873.
148.
Roehr CC, te Pas AB, Dold SK, Breindahl M, Blennow M, Rüdiger M, Gupta S: Investigating the European perspective of neonatal point-of-care echocardiography in the neonatal intensive care unit - a pilot study. Eur J Pediatr 2013;172:907-911.
149.
Subhedar NV, Shaw NJ: Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev 2003;3:CD001242.
150.
Ruoss JL, McPherson C, DiNardo J: Inotrope and vasopressor support in neonates. Neoreviews 2015;16:e351-e361.
151.
Dempsey EM, Barrington KJ, Marlow N, O'Donnell CP, Miletin J, Naulaers G, et al; HIP Consortium: Management of Hypotension in Preterm infants (The HIP Trial): a randomised controlled trial of hypotension management in extremely low gestational age newborns. Neonatology 2014;105:275-281.
152.
Paradisis M, Osborn DA: Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise. Cochrane Database Syst Rev 2004;1:CD003958.
153.
Ibrahim H, Sinha IP, Subhedar NV: Corticosteroids for treating hypotension in preterm infants. Cochrane Database Syst Rev 2011;12:CD003662.
154.
Whyte R, Kirpalani H: Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants. Cochrane Database Syst Rev 2011;11:CD000512.
155.
Whyte RK, Kirpalani H, Asztalos EV, Andersen C, Blajchman M, Heddle N, et al; PINTOS Study Group: Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics 2009;123:207-213.
157.
Weisz DE, More K, McNamara PJ, Shah PS: PDA ligation and health outcomes: a meta-analysis. Pediatrics 2014;133:e1024-e1046.
158.
Heuchan AM, Clyman RI: Managing the patent ductus arteriosus: current treatment options. Arch Dis Child Fetal Neonatal Ed 2014;99:F431-F436.
159.
Ohlsson A, Walia R, Shah SS: Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev 2015;2:CD003481.
160.
Ohlsson A, Shah PS: Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants. Cochrane Database Syst Rev 2015;3:CD010061.
161.
Kluckow M, Jeffery M, Gill A, Evans N: A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2014;99:F99-F104.
163.
Hummel P, Lawlor-Klean P, Weiss MG: Validity and reliability of the N-PASS assessment tool with acute pain. J Perinatol 2010;30:474-478.
164.
Durrmeyer X, Dahan S, Delorme P, Blary S, Dassieu G, Caeymaex L, Carbajal R: Assessment of atropine-sufentanil-atracurium anaesthesia for endotracheal intubation: an observational study in very premature infants. BMC Pediatr 2014;14:120.
165.
Dekker J, Lopriore E, Rijken M, Rijntjes-Jacobs E, Smits-Wintjens V, te Pas A: Sedation during minimally invasive surfactant therapy in preterm infants. Neonatology 2016;109:308-313.
166.
Bellù R, de Waal K, Zanini R: Opioids for neonates receiving mechanical ventilation: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2010;95:F241-F251.
167.
Stevens B, Yamada J, Lee GY, Ohlsson A: Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev 2013;1:CD001069.
168.
Tan K, Lai NM, Sharma A: Surfactant for bacterial pneumonia in late preterm and term infants. Cochrane Database Syst Rev 2012;2:CD008155.
169.
Vento G, Tana M, Tirone C, Aurilia C, Lio A, Perelli S, Ricci C, Romagnoli C: Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection. Acta Biomed 2012;83 (suppl 1):33-36.
170.
Aziz A, Ohlsson A: Surfactant for pulmonary haemorrhage in neonates. Cochrane Database Syst Rev 2012;7:CD005254.
171.
Bozdağ Ş, Dilli D, Gökmen T, Dilmen U: Comparison of two natural surfactants for pulmonary hemorrhage in very low-birth-weight infants: a randomized controlled trial. Am J Perinatol 2015;32:211-218.
172.
Askie LM, Ballard RA, Cutter GR, Dani C, Elbourne D, Field D, Hascoet JM, et al; Meta-Analysis of Preterm Patients on Inhaled Nitric Oxide Collaboration: Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials. Pediatrics 2011;128:729-739.
173.
Breatnach CR, Flanagan F, James A, Corcoran JD, Franklin O, El-Khuffash A: The use of inhaled nitric oxide in a tertiary neonatal intensive care unit. Ir Med J 2015;108:275-278.
174.
Ellsworth MA, Harris MN, Carey WA, Spitzer AR, Clark RH: Off-label use of inhaled nitric oxide after release of NIH consensus statement. Pediatrics 2015;135:643-648.
175.
Shah DM, Kluckow M: Early functional echocardiogram and inhaled nitric oxide: usefulness in managing neonates born following extreme preterm premature rupture of membranes (PPROM). J Paediatr Child Health 2011;47:340-345.
176.
Cheng DR, Peart S, Tan K, Sehgal A: Nitric therapy in preterm infants: rationalised approach based on functional neonatal echocardiography. Acta Paediatr 2016;105:165-171.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.